Trade CSPC Pharmaceutical Group Limited - 1093 CFD

About CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, CSPC Pharmaceutical Group Ltd revenues increased 12% to RMB27.87B. Net income increased 9% to RMB5.61B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling and distribution expenses increase of 11% to RMB10.44B (expense), Research and development expenses increase of 19% to RMB3.43B (expense).